Big Pharma knows when it’s losing its grip on the American people, and last week’s White House moves proved it. On The Record with Greta Van Susteren, Dr. Mehmet Oz applauded President Trump’s aggressive push to cut prescription costs, highlighting that the administration is poised to expand Medicare coverage for certain obesity drugs and make lifesaving treatments more affordable for seniors.
The facts are straightforward: the administration has been negotiating with Eli Lilly and Novo Nordisk to slash prices on GLP‑1 obesity drugs, roll out those lower prices through a TrumpRx direct‑to‑consumer channel, and extend coverage to Medicare and Medicaid beneficiaries under targeted conditions. Reported price targets range from starter doses at roughly $149 a month to broader discounts in the $245–$350 range, with Medicare copays capped to protect seniors.
This is conservative governance at its best — using American bargaining power to force price concessions and cut out the middlemen who have been padding pharma profits for decades. Dr. Oz rightly called the president’s executive order a “powerful” and fair rebalance for patients who too often skip medications because of cost, and that kind of common‑sense action is what voters want.
Let’s be clear: the drug giants aren’t handing these concessions out of the goodness of their corporate hearts. The White House deal reportedly includes incentives and temporary tariff relief, and companies will see gains from expanded government coverage and new consumer channels. Conservatives should celebrate the win for American families while demanding transparency about the quid pro quo so taxpayers aren’t bled dry in the name of corporate appeasement.
We should also guard against the left’s politicized take that only big government can fix healthcare. This deal, negotiated by a pro‑market administration, shows you can get lower prices by forcing competition, cutting middlemen, and holding corporations accountable — not by throwing more dollars and mandates at a broken system. At the same time, every conservative worth his salt should watch for creeping entitlement expansion and ensure eligibility rules focus on patients with real medical need, not massified dependence on a profit engine.
America’s fight with Big Pharma is far from over, but this moment proves a simple truth: when patriots in government and principled public servants like Dr. Oz stand with working families, the swamp doesn’t stand a chance. Hardworking Americans deserve relief from crippling drug costs, and they deserve a government that uses muscle, not surrender, to defend their pocketbooks and their health.
